Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引:70
作者
Eichenauer, D. A. [1 ,2 ]
Engert, A. [1 ,2 ]
Dreyling, M. [3 ]
机构
[1] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany
[2] German Hodgkin Study Grp GHSG, Cologne, Germany
[3] Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadern, Dept Med 3, Munich, Germany
[4] ESMO Head Off, CH-6962 Viganello Lugano, Switzerland
关键词
STEM-CELL TRANSPLANTATION; INVOLVED-FIELD RADIOTHERAPY; 2; CYCLES; RETROSPECTIVE ANALYSIS; CHEMOTHERAPY; PREDOMINANT; INTENSITY; DISEASE; PROGRESSION; SURVIVAL;
D O I
10.1093/annonc/mdr378
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:vi55 / vi58
页数:4
相关论文
共 26 条
[11]   Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease [J].
Ferme, Christophe ;
Eghbali, Houchingue ;
Meerwaldt, Jacobus H. ;
Rieux, Chantal ;
Bosq, Jacques ;
Berger, Francoise ;
Girinsky, Theodore ;
Brice, Pauline ;
van't Veer, Mars B. ;
Walewski, Jan A. ;
Lederlin, Pierre ;
Tirelli, Umberto ;
Carde, Patrice ;
Van den Neste, Eric ;
Gyan, Emmanuel ;
Monconduit, Mathieu ;
Divine, Marine ;
Raemaekers, John M. M. ;
Salles, Gilles ;
Noordijk, Evert M. ;
Creemers, Geert-Jan ;
Gabarre, Jean ;
Hagenbeek, Anton ;
Reman, Oumedaly ;
Blanc, Michel ;
Thomas, Jose ;
Vie, Brigitte ;
Kluin-Nelemans, Johanna C. ;
Viseu, Fernando ;
Baars, Joke W. ;
Poortmans, Philip ;
Lugtenburg, Pieternella J. ;
Carrie, Christian ;
Jaubert, Jerome ;
Henry-Amar, Michel .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (19) :1916-1927
[12]   Early interim 2-[18F]Fluoro-2-Deoxy-D-Glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma:: A report from a joint Italian-Danish study [J].
Gallamini, Andrea ;
Hutchings, Martin ;
Rigacci, Luigi ;
Specht, Lena ;
Merli, Francesco ;
Hansen, Mads ;
Patti, Caterina ;
Loft, Annika ;
Di Raimondo, Francesco ;
D'Amore, Francesco ;
Biggi, Alberto ;
Vitolo, Umberto ;
Stelitano, Caterina ;
Sancetta, Rosario ;
Trentin, Livio ;
Luminari, Stefano ;
Iannitto, Emilio ;
Viviani, Simonetta ;
Pierri, Ivana ;
Levis, Alessandro .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) :3746-3752
[13]   FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma [J].
Hutchings, M ;
Loft, A ;
Hansen, M ;
Pedersen, LM ;
Buhl, T ;
Jurlander, J ;
Buus, S ;
Keiding, S ;
D'Amore, F ;
Boesen, AM ;
Berthelsen, AK ;
Specht, L .
BLOOD, 2006, 107 (01) :52-59
[14]   Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma:: A retrospective analysis from the German Hodgkin Lymphoma Study Group [J].
Josting, A ;
Nogová, L ;
Franklin, J ;
Glossmann, JP ;
Eich, HT ;
Sieber, M ;
Schober, T ;
Boettcher, HD ;
Schulz, U ;
Müller, RP ;
Diehl, V ;
Engert, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) :1522-1529
[15]   Time-intensified dexamethasone/cisplatin/cytarabine:: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease [J].
Josting, A ;
Rudolph, C ;
Reiser, M ;
Mapara, M ;
Sieber, M ;
Kirchner, HH ;
Dörken, B ;
Hossfeld, DK ;
Diehl, V ;
Engert, A .
ANNALS OF ONCOLOGY, 2002, 13 (10) :1628-1635
[16]   Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma [J].
Moskowitz, Alison J. ;
Yahalom, Joachim ;
Kewalramani, Tarun ;
Maragulia, Jocelyn C. ;
Vanak, Jill M. ;
Zelenetz, Andrew D. ;
Moskowitz, Craig H. .
BLOOD, 2010, 116 (23) :4934-4937
[17]   A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model [J].
Moskowitz, CH ;
Nimer, SD ;
Zelenetz, AD ;
Trippett, T ;
Hedrick, EE ;
Filippa, D ;
Louie, D ;
Gonzales, M ;
Walits, J ;
Coady-Lyons, N ;
Qin, J ;
Frank, R ;
Bertino, JR ;
Coy, A ;
Noy, A ;
O'Brien, JP ;
Straus, D ;
Portlock, CS ;
Yahalom, J .
BLOOD, 2001, 97 (03) :616-623
[18]   Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage 1A lymphocyte-predominant Hodgkin's lymphoma:: a retrospective analysis from the German Hodgkin Study Group (GHSG) [J].
Nogová, L ;
Reineke, T ;
Eich, HT ;
Josting, A ;
Müller-Hermelink, HK ;
Wingbermühle, K ;
Brillant, C ;
Gossmann, A ;
Oertel, J ;
Bollen, MV ;
Müller, RP ;
Diehl, V ;
Engert, A .
ANNALS OF ONCOLOGY, 2005, 16 (10) :1683-1687
[19]   Lymphocyte-predominant and classical Hodgkin's lymphoma:: A comprehensive analysis from the German Hodgkin study group [J].
Nogova, Lucia ;
Reineke, Thorsten ;
Brillant, Corinne ;
Sieniawski, Michal ;
Ruediger, Thomas ;
Josting, Andreas ;
Bredenfeld, Henning ;
Skripnitchenko, Roman ;
Mueller, Rolf-Peter ;
Mueller-Hermelink, Hans-Konrad ;
Diehl, Volker ;
Engert, Andreas .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) :434-439
[20]   Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome [J].
Robinson, Stephen P. ;
Sureda, Anna ;
Canals, Carmen ;
Russell, Nigel ;
Caballero, Dolores ;
Bacigalupos, Andrea ;
Iriondo, Arturo ;
Cook, Gordon ;
Pettitt, Andrew ;
Socie, Gerard ;
Bonifazi, Francesca ;
Bosi, Alberto ;
Michallet, Mauricette ;
Liakopoulou, Effie ;
Maertens, Johan ;
Passweg, Jakob ;
Clarke, Fiona ;
Martin, Rodrigo ;
Schmitz, Norbert .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (02) :230-238